Skip to content

Predicting Oral Mucositis Risk in Head and Neck Cancer Patients Undergoing Radiotherapy: The Role of D-Dimer/Fibrinogen Ratio

Predictive Value of Plasma D-Dimer/Fibrinogen Ratio (DFR) for Radiation-Induced Oral Mucositis (RIOM) in Patients with Head and Neck Cancer: A Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124972
Enrollment
Unknown
Registered
2026-05-19
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation-induced oral mucositis

Interventions

Non-RIOM group vs. RIOM group:None

Sponsors

Southern Medical University Southern Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Voluntarily provided written informed consent. 2. Age >= 18 years. 3. Pathologically diagnosed with nasopharyngeal carcinoma or head and neck cancer. 4. Patients judged by treating physicians to require radiotherapy.

Exclusion criteria

Exclusion criteria: 1. Presence of contraindications to radiotherapy. 2. Concurrent other malignancies. 3. Presence of any severe comorbidities that may pose unacceptable risks or adversely affect study compliance, such as unstable cardiac diseases requiring treatment, chronic hepatitis, renal diseases, poor general condition, uncontrolled diabetes mellitus (fasting blood glucose>1.5×ULN), and psychiatric disorders. 4. Deemed unsuitable for enrollment in this study at the investigator’s discretion.

Design outcomes

Primary

MeasureTime frame
Plasma D-dimer/fibrinogen ratio;Radiotherapy-induced Oral Mucositis, RIOM;

Secondary

MeasureTime frame
Quality of life, QoL;

Countries

China

Contacts

Public ContactChen Yuhan

Southern Medical University Southern Hospital

cspnr1@126.com+86 20 62787487

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026